Commensal-Specific CD4+ Cells From Patients With Crohn's Disease Have a T-Helper 17 Inflammatory Profile

Gastroenterology

Volumn 151, Issue 3, 2016, Pages 489-500.e3

  Calderón Gómez, Elisabeth ^a   Bassolas Molina, Helena ^a   Mora Buch, Rut ^a   Dotti, Isabella ^a   Planell, Núria ^a   Esteller, Míriam ^a   Gallego, Marta ^a   Martí, Mercè ^b   Garcia Martín, Carme ^b   Martínez Torró, Carlos ^b   Ordás, Ingrid ^a   Singh, Sharat ^c   Panés, Julian ^a   Benítez Ribas, Daniel ^a   Salas, Azucena ^a  

^a INSTITUTO DE SALUD CARLOS III   (Spain)

^b UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^c Prometheus Laboratories   (United States)

Author keywords

Antigen Specific Immune Response; Effector T Cells; IBD; Immunity

Indexed keywords

ANTIBODY; BACTERIAL PROTEIN; CARBOXYFLUORESCEIN DIACETATE SUCCINIMIDYL ESTER; CD4 ANTIGEN; CXCL1 CHEMOKINE; GAMMA INTERFERON; INTERLEUKIN 17; INTERLEUKIN 7; INTERLEUKIN 8; MACROPHAGE INFLAMMATORY PROTEIN 3ALPHA; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; PROTEIN A4 FLA2; PROTEIN ASCA AG; PROTEIN FLAX; PROTEIN TT; PROTEIN YIDX; T LYMPHOCYTE RECEPTOR; TRANSCRIPTION FACTOR T BET; TUMOR NECROSIS FACTOR; UNCLASSIFIED DRUG; CHEMOKINE; CYTOKINE;

ANTIBODY RESPONSE; ANTIGEN SPECIFICITY; ARTICLE; CD4+ T LYMPHOCYTE; CELLULAR IMMUNITY; CONTROLLED STUDY; CROHN DISEASE; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DISEASE DURATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; INFLAMMATORY CELL; INTESTINE CRYPT; INTESTINE EPITHELIUM; INTESTINE EPITHELIUM CELL; INTESTINE RESECTION; LYMPHOCYTE PROLIFERATION; MAJOR CLINICAL STUDY; MALE; NUCLEOTIDE SEQUENCE; PERIPHERAL BLOOD MONONUCLEAR CELL; PHENOTYPE; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; TH1 CELL; TH17 CELL; ADULT; BLOOD; CASE CONTROL STUDY; IMMUNOLOGY; INTESTINE FLORA; INTESTINE MUCOSA; MICROBIOLOGY; MIDDLE AGED; SYMBIOSIS;

ADULT; ANTIBODIES; BACTERIAL PROTEINS; CASE-CONTROL STUDIES; CD4-POSITIVE T-LYMPHOCYTES; CHEMOKINES; CROHN DISEASE; CYTOKINES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; GASTROINTESTINAL MICROBIOME; HUMANS; INTESTINAL MUCOSA; MALE; MIDDLE AGED; REAL-TIME POLYMERASE CHAIN REACTION; SYMBIOSIS; TH17 CELLS;

EID: 84991225349     PISSN: 00165085     EISSN: 15280012     Source Type: Journal    
DOI: 10.1053/j.gastro.2016.05.050     Document Type: Article

References (54)

1. 1 Berg, D.J., Davidson, N., Kuhn, R., et al. Enterocolitis and colon cancer in interleukin-10-deficient mice are associated with aberrant cytokine production and CD4(+) TH1-like responses. J Clin Invest 98 (1996), 1010–1020.
2. 2 Cong, Y., Brandwein, S.L., McCabe, R.P., et al. CD4+ T cells reactive to enteric bacterial antigens in spontaneously colitic C3H/HeJBir mice: increased T helper cell type 1 response and ability to transfer disease. J Exp Med 187 (1998), 855–864.
3. 3 Targan, S.R., Landers, C.J., Yang, H., et al. Antibodies to CBir1 flagellin define a unique response that is associated independently with complicated Crohn's disease. Gastroenterology 128 (2005), 2020–2028.
4. 4 Elson, C.O., Cong, Y., McCracken, V.J., et al. Experimental models of inflammatory bowel disease reveal innate, adaptive, and regulatory mechanisms of host dialogue with the microbiota. Immunol Rev 206 (2005), 260–276.
5. 5 Main, J., McKenzie, H., Yeaman, G.R., et al. Antibody to Saccharomyces cerevisiae (bakers' yeast) in Crohn's disease. BMJ 297 (1988), 1105–1106.
6. 6 Landers, C.J., Cohavy, O., Misra, R., et al. Selected loss of tolerance evidenced by Crohn's disease-associated immune responses to auto- and microbial antigens. Gastroenterology 123 (2002), 689–699.
7. 7 Lodes, M.J., Cong, Y., Elson, C.O., et al. Bacterial flagellin is a dominant antigen in Crohn disease. J Clin Invest 113 (2004), 1296–1306.
8. 8 Schoepfer, A.M., Schaffer, T., Mueller, S., et al. Phenotypic associations of Crohn's disease with antibodies to flagellins A4-Fla2 and Fla-X, ASCA, p-ANCA, PAB, and NOD2 mutations in a Swiss Cohort. Inflamm Bowel Dis 15 (2009), 1358–1367.
9. 9 Duck, L.W., Walter, M.R., Novak, J., et al. Isolation of flagellated bacteria implicated in Crohn's disease. Inflamm Bowel Dis 13 (2007), 1191–1201.
10. 10 Chen, C.S., Sullivan, S., Anderson, T., et al. Identification of novel serological biomarkers for inflammatory bowel disease using Escherichia coli proteome chip. Mol Cell Proteomics 8 (2009), 1765–1776.
11. 11 Ferrante, M., Henckaerts, L., Joossens, M., et al. New serological markers in inflammatory bowel disease are associated with complicated disease behaviour. Gut 56 (2007), 1394–1403.
12. 12 Mow, W.S., Vasiliauskas, E.A., Lin, Y.C., et al. Association of antibody responses to microbial antigens and complications of small bowel Crohn's disease. Gastroenterology 126 (2004), 414–424.
13. 13 Arnott, I.D., Landers, C.J., Nimmo, E.J., et al. Sero-reactivity to microbial components in Crohn's disease is associated with disease severity and progression, but not NOD2/CARD15 genotype. Am J Gastroenterol 99 (2004), 2376–2384.
14. 14 Lichtenstein, G.R., Emerging prognostic markers to determine Crohn's disease natural history and improve management strategies: a review of recent literature. Gastroenterol Hepatol (N Y) 6 (2010), 99–107.
15. 15 van Schaik, F.D., Oldenburg, B., Hart, A.R., et al. Serological markers predict inflammatory bowel disease years before the diagnosis. Gut 62 (2013), 683–688.
16. 16 Shen, C., Landers, C.J., Derkowski, C., et al. Enhanced CBir1-specific innate and adaptive immune responses in Crohn's disease. Inflamm Bowel Dis 14 (2008), 1641–1651.
17. 17 Tomita, T., Kanai, T., Nemoto, Y., et al. Colitogenic CD4+ effector-memory T cells actively recirculate in chronic colitic mice. Inflamm Bowel Dis 14 (2008), 1630–1640.
18. 18 Parronchi, P., Romagnani, P., Annunziato, F., et al. Type 1 T-helper cell predominance and interleukin-12 expression in the gut of patients with Crohn's disease. Am J Pathol 150 (1997), 823–832.
19. 19 Fujino, S., Andoh, A., Bamba, S., et al. Increased expression of interleukin 17 in inflammatory bowel disease. Gut 52 (2003), 65–70.
20. 20 Kleinschek, M.A., Boniface, K., Sadekova, S., et al. Circulating and gut-resident human Th17 cells express CD161 and promote intestinal inflammation. J Exp Med 206 (2009), 525–534.
21. 21 Veny, M., Esteller, M., Ricart, E., et al. Late Crohn's disease patients present an increase in peripheral Th17 cells and cytokine production compared with early patients. Aliment Pharmacol Ther 31 (2010), 561–572.
22. 22 Rovedatti, L., Kudo, T., Biancheri, P., et al. Differential regulation of interleukin 17 and interferon gamma production in inflammatory bowel disease. Gut 58 (2009), 1629–1636.
23. 23 Duchmann, R., Kaiser, I., Hermann, E., et al. Tolerance exists towards resident intestinal flora but is broken in active inflammatory bowel disease (IBD). Clin Exp Immunol 102 (1995), 448–455.
24. 24 Duchmann, R., May, E., Heike, M., et al. T cell specificity and cross reactivity towards enterobacteria, bacteroides, bifidobacterium, and antigens from resident intestinal flora in humans. Gut 44 (1999), 812–818.
25. 25 Duchmann, R., Marker-Hermann, E., Meyer zum Buschenfelde KH. Bacteria-specific T-cell clones are selective in their reactivity towards different enterobacteria or H. pylori and increased in inflammatory bowel disease. Scand J Immunol 44 (1996), 71–79.
26. 26 Jung, P., Sato, T., Merlos-Suarez, A., et al. Isolation and in vitro expansion of human colonic stem cells. Nat Med 17 (2011), 1225–1227.
27. 27 Coukos, J.A., Howard, L.A., Weinberg, J.M., et al. ASCA IgG and CBir antibodies are associated with the development of Crohn's disease and fistulae following ileal pouch-anal anastomosis. Dig Dis Sci 57 (2012), 1544–1553.
28. 28 Annunziato, F., Cosmi, L., Santarlasci, V., et al. Phenotypic and functional features of human Th17 cells. J Exp Med 204 (2007), 1849–1861.
29. 29 Ramesh, R., Kozhaya, L., McKevitt, K., et al. Pro-inflammatory human Th17 cells selectively express P-glycoprotein and are refractory to glucocorticoids. J Exp Med 211 (2014), 89–104.
30. 30 Lee, J.W., Wang, P., Kattah, M.G., et al. Differential regulation of chemokines by IL-17 in colonic epithelial cells. J Immunol 181 (2008), 6536–6545.
31. 31 Blaser, M.J., Miller, R.A., Lacher, J., et al. Patients with active Crohn's disease have elevated serum antibodies to antigens of seven enteric bacterial pathogens. Gastroenterology 87 (1984), 888–894.
32. 32 Macpherson, A., Khoo, U.Y., Forgacs, I., et al. Mucosal antibodies in inflammatory bowel disease are directed against intestinal bacteria. Gut 38 (1996), 365–375.
33. 33 Sutton, C.L., Kim, J., Yamane, A., et al. Identification of a novel bacterial sequence associated with Crohn's disease. Gastroenterology 119 (2000), 23–31.
34. 34 Konrad, A., Rutten, C., Flogerzi, B., et al. Immune sensitization to yeast antigens in ASCA-positive patients with Crohn's disease. Inflamm Bowel Dis 10 (2004), 97–105.
35. 35 Ergin, A., Syrbe, U., Scheer, R., et al. Impaired peripheral Th1 CD4+ T cell response to Escherichia coli proteins in patients with Crohn's disease and ankylosing spondylitis. J Clin Immunol 31 (2011), 998–1009.
36. 36 Pette, M., Fujita, K., Kitze, B., et al. Myelin basic protein-specific T lymphocyte lines from MS patients and healthy individuals. Neurology 40 (1990), 1770–1776.
37. 37 Zhang, J., Markovic-Plese, S., Lacet, B., et al. Increased frequency of interleukin 2-responsive T cells specific for myelin basic protein and proteolipid protein in peripheral blood and cerebrospinal fluid of patients with multiple sclerosis. J Exp Med 179 (1994), 973–984.
38. 38 Cao, Y., Goods, B.A., Raddassi, K., et al. Functional inflammatory profiles distinguish myelin-reactive T cells from patients with multiple sclerosis. Sci Transl Med, 7, 2015, 287ra74.
39. 39 Christmann, B.S., Abrahamsson, T.R., Bernstein, C.N., et al. Human seroreactivity to gut microbiota antigens. J Allergy Clin Immunol, 136, 2015, 1378.
40. 40 Globig, A.M., Hennecke, N., Martin, B., et al. Comprehensive intestinal T helper cell profiling reveals specific accumulation of IFN-gamma+IL-17+coproducing CD4+ T Cells in active inflammatory bowel disease. Inflamm Bowel Dis 20 (2014), 2321–2329.
41. 41 Harbour, S.N., Maynard, C.L., Zindl, C.L., et al. Th17 cells give rise to Th1 cells that are required for the pathogenesis of colitis. Proc Natl Acad Sci U S A 112 (2015), 7061–7066.
42. 42 Hand, T.W., Dos Santos, L.M., Bouladoux, N., et al. Acute gastrointestinal infection induces long-lived microbiota-specific T cell responses. Science 337 (2012), 1553–1556.
43. 43 Goyette, P., Boucher, G., Mallon, D., et al. High-density mapping of the MHC identifies a shared role for HLA-DRB1*01:03 in inflammatory bowel diseases and heterozygous advantage in ulcerative colitis. Nat Genet 47 (2015), 172–179.
44. 44 Hueber, W., Sands, B.E., Lewitzky, S., et al. Secukinumab, a human anti-IL-17A monoclonal antibody, for moderate to severe Crohn's disease: unexpected results of a randomised, double-blind placebo-controlled trial. Gut 61 (2012), 1693–1700.
45. 45 Targan, S.R. Feagan, B.G., Vermiere, S., Panaccione, R., et al. Mo2083 A randomized, double-blind, placebo-controlled study to evaluate the safety, tolerability, and efficacy of AMG827 in subjects with moderate to severe Crohn's disease. Gastroenterology, 143, 2012, e26.
46. 46 Hueber, W., Patel, D.D., Dryja, T., et al. Effects of AIN457, a fully human antibody to interleukin-17A, on psoriasis, rheumatoid arthritis, and uveitis. Sci Transl Med, 2, 2010, 52ra72.
47. 47 Korn, T., Bettelli, E., Oukka, M., et al. IL-17 and Th17 cells. Annu Rev Immunol 27 (2009), 485–517.
48. 48 Hovhannisyan, Z., Treatman, J., Littman, D.R., et al. Characterization of interleukin-17-producing regulatory T cells in inflamed intestinal mucosa from patients with inflammatory bowel diseases. Gastroenterology 140 (2011), 957–965.
49. 1 Gentelman, R.C., Carey, V.J., Bates, D.M., et al. Bioconductor: open software development for computational biology and bioinformatics. Genome Biol, 5, 2004 5:R80.
50. 2 R Core Team. R: a language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria 2014.
51. 3 Jung, P., Sato, T., Merlos-Suarez, A., et al. Isolation and in vitro expansion of human colonic stem cells. Nat Med 17 (2011), 1225–1227.
52. 4 Chitnis, V., Pahwa, S., Evaluation of the T-cell receptor repertoire. Rose, N.R., Hamilton, R.G., Detrick, B., (eds.) Evaluation of the T-cell receptor repertoire. Manuals of Clinical Laboratory Immunology, 2002, ASM Press, Washington DC, USA, 244–255.
53. 5 Fozza, C., Contini, S., Galleu, A., et al. Patients with myelodysplastic syndromes display several T-cell expansions, which are mostly polyclonal in the CD4(+) subset and oligoclonal in the CD8(+) subset. Exp Hematol 37 (2009), 947–955.
54. 6 Kou, Z.C., Puhr, J.S., Rojas, M., et al. T-cell receptor Vbeta repertoire CDR3 length diversity differs within CD45RA and CD45RO T-cell subsets in healthy and human immunodeficiency virus-infected children. Clin Diagn Lab Immunol 7 (2000), 953–959.